ACTA1 and pachyonychia congenita: Western blot result showed that lncIAPF overexpression significantly increased the expression levels of FAP1, S100A4, vimentin, α-SMA, and collagen I and III, which reversed the therapeutic effect of C-PC (Fig. 3B).